Goldman Sachs led U.S. equity underwriting in Q3 with $666M, up 43% YoY, as AI-linked IPOs and big offerings kept ECM ...

The first thing we see is a tree. Towering towards the sky, this darkly shaded cedar tree dominates the frame. After a minute of blood-red title credits and dissonant underscoring, the cut to this ...

Semiconductors, financial services and space technology led for new Unicorn Board counts with the remainder hailing from a ...

I never thought I'd get to see a B-2 Spirit stealth bomber in person. The advanced warplanes, which cost around $2 billion each, can evade radar detection and drop tens of thousands of pounds of ...

Stealth BioTherapeutics' filing for rare disease drug elamipretide has been turned down by the FDA, although the company says the US regulator has given it a "path forward" for the programme.